PRE-INDUCTION WITH FOUR WEEKLY HIGH-DOSE CYTARABINE, REDUCES MORTALITY RATE AND PROLONGS PROGRESSION FREE SURVIVAL IN ACUTE MYELOGENOUS LEUKEMIA (AML), A COMPARATIVE STUDY
EHA Library, Maher Salamoon,
421196
VENETOCLAX PLUS HOMOHARRINGTONINE WITH CYTARABINE AND ACLARUBICIN AS INDUCTION THERAPY FOR YOUNG ADULTS WITH DE NOVO ACUTE MYELOID LEUKEMIA: A PROSPECTIVE, SINGLE-ARM, MULTICENTER, PHASE 2 STUDY
EHA Library, Huafeng Wang,
421221